MAPK3 and colorectal carcinoma: Studies have also revealed that silibinin strongly inhibits PI-3K-AKT–mTOR but activates MEK1/2-ERK1/2 pathways for its biological effects manifested in terms of induction of autophagic type PCD in CRC cells (Raina et al., 2013a).